Novel companion biomarker assay for glioma cancer drug development to overcome current lack of in-vitro test success
Lead Participant:
DESTINA GENOMICS LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| DESTINA GENOMICS LIMITED | £17,250 | £ 9,041 |
Participant |
||
| UNIVERSITY OF EDINBURGH | £15,586 | £ 15,586 |
People |
ORCID iD |